Purple Biotech Ltd. (PPBT)

NASDAQ: PPBT · IEX Real-Time Price · USD
0.670
+0.050 (8.06%)
At close: Mar 28, 2024, 4:00 PM
0.685
+0.015 (2.24%)
After-hours: Mar 28, 2024, 7:56 PM EDT

Total Valuation

Purple Biotech has a market cap or net worth of $19.02 million. The enterprise value is $3.96 million.

Market Cap 19.02M
Enterprise Value 3.96M

Important Dates

The last earnings date was Tuesday, March 5, 2024, before market open.

Earnings Date Mar 5, 2024
Ex-Dividend Date n/a

Share Statistics

Purple Biotech has 25.94 million shares outstanding.

Shares Outstanding 25.94M
Owned by Insiders (%) 3.96%
Owned by Institutions (%) 9.16%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.56
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 0.20
EV / Sales n/a
EV / EBITDA 0.18
EV / EBIT 0.18
EV / FCF n/a

Financial Position

The company has a current ratio of 2.20, with a Debt / Equity ratio of 0.01.

Current Ratio 2.20
Quick Ratio n/a
Debt / Equity 0.01
Debt / EBITDA 0.02
Debt / FCF n/a
Interest Coverage 10.06

Financial Efficiency

Return on equity (ROE) is 49.00% and return on invested capital (ROIC) is -64.45%.

Return on Equity (ROE) 49.00%
Return on Assets (ROA) 41.70%
Return on Capital (ROIC) -64.45%
Revenue Per Employee n/a
Profits Per Employee $994,000
Employee Count 20
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -61.93% in the last 52 weeks. The beta is 0.57, so Purple Biotech's price volatility has been lower than the market average.

Beta (1Y) 0.57
52-Week Price Change -61.93%
50-Day Moving Average 0.72
200-Day Moving Average 1.04
Relative Strength Index (RSI) 45.34
Average Volume (30 Days) 100,696

Short Selling Information

Short Interest 223,002
Short Previous Month 295,900
Short % of Shares Out 6.95%
Short % of Float n/a
Short Ratio (days to cover) 1.83

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -22.27M
Pretax Income 19.88M
Net Income 19.88M
EBITDA 22.27M
EBIT 22.08M
Earnings Per Share (EPS) -$0.90
Full Income Statement

Balance Sheet

The company has $15.41 million in cash and $351,000 in debt, giving a net cash position of $15.06 million or $0.58 per share.

Cash & Cash Equivalents 15.41M
Total Debt 351,000
Net Cash 15.06M
Net Cash Per Share $0.58
Equity / Book Value 34.21M
Book Value Per Share 1.32
Working Capital 8.61M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$19.93 million and capital expenditures -$3,000, giving a free cash flow of -$19.93 million.

Operating Cash Flow -19.93M
Capital Expenditures -3,000
Free Cash Flow -19.93M
FCF Per Share -$1.01
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Purple Biotech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -11.37%
Shareholder Yield -11.37%
Earnings Yield 104.54%
FCF Yield -104.79%

Analyst Forecast

The average price target for Purple Biotech is $10.00, which is 1,392.54% higher than the current price. The consensus rating is "Strong Buy".

Price Target $10.00
Price Target Difference 1,392.54%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on August 21, 2020. It was a reverse split with a ratio of 1:10.

Last Split Date Aug 21, 2020
Split Type Reverse
Split Ratio 1:10

Scores

Altman Z-Score n/a
Piotroski F-Score 3